Skip to main content
Redox Biology logoLink to Redox Biology
. 2021 Nov 19;48:102191. doi: 10.1016/j.redox.2021.102191

Corrigendum to”Synergistic antitumor activity of rapamycin and EF24 via increasing ROS for the treatment of gastric cancer”. [Redox Biol 10 (2016) 78–89 [201222–008501] [211009–007504]

Weiqian Chen a,b, Peng Zou a,c, Zhongwei Zhao b, Xi Chen a, Xiaoxi Fan b, Rajamanickam Vinothkumar a, Ri Cui a, Fazong Wu b, Qianqian Zhang b, Guang Liang a,c,∗∗, Jiansong Ji a,b,
PMCID: PMC8710982  PMID: 34802996

The authors regret < unintentionally used the same GAPDH images in the two figures (the GAPDH band in Fig. 2E in SGC7901 cells and the GAPDH band in Fig. 5B in BGC823 cells)>.

The authors would like to apologise for any inconvenience caused.

Figure. 5

Image 1

Contributor Information

Guang Liang, Email: wzmcliangguang@163.com.

Jiansong Ji, Email: jjstcty@sina.com.


Articles from Redox Biology are provided here courtesy of Elsevier

RESOURCES